학술논문

Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1
Document Type
Journal
Source
HEMASPHERE; DEC 2020, 4 6, pe489 4p.
Subject
Language
English
ISSN
25729241